https://pubmed.ncbi.nlm.nih.gov/10841798/
Adenosine receptor agonists have cardioprotective, cerebroprotective, and antiinflammatory properties. We report that a carbocyclic modification of the ribose...
purine nucleosidesanaloguespotentselectiveadenosine
https://pubmed.ncbi.nlm.nih.gov/39815782/?utm_source=newsletter.robinberzinmd.com&utm_medium=newsletter&utm_campaign=should-we-all-be-microdosing-glp-1s
GLP-1 RAs appear to have a positive effect upon mitochondria area, number and morphology, but effects upon other aspects of mitochondrial health remain...
the effectsreceptor agonistsglucagonlikepeptide
https://www.health.com/glp-1-receptor-agonists-8624663
Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes, high blood sugar, and obesity by regulating insulin production.
receptor agonistsside effectsglpusestypes
https://www.bath.ac.uk/publications/chronic-effects-of-g-protein-biased-mu-opioid-receptor-agonists-in-the-brain/
This project takes a co-ordinated transdisciplinary approach, using a combination of in vivo and ex vivo techniques.
mu opioid receptorg proteinchroniceffectsbiased
https://pubmed.ncbi.nlm.nih.gov/28620298/
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a bridging role in innate immunity and adaptive immunity. The activated TLRs...
toll like receptorantitumoractivityagonists
https://www.mdpi.com/2077-0383/13/21/6336
Background: The increased popularity and ubiquitous use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of diabetes, heart failure,...
scoping reviewreceptor agonistsglp
https://www.law360.com/healthcare-authority/cases/65c0fec7ff070b025f43c400/articles
Coverage of federal case GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION, case number 2:24-md-03094, from Pennsylvania...
receptor agonistsglucagonlikepeptideglp